Why the study?
Does platelet-activating factor acetylhydrolase play a proatherogenic or antiatherogenic role in atherosclerosis?
Does platelet-activating factor acetylhydrolase play a proatherogenic or antiatherogenic role in atherosclerosis?
This review highlights the conflicting evidence regarding PAF-AH in atherosclerosis, suggesting it may have protective anti-inflammatory properties rather than being purely a proatherogenic risk factor.
Authors
No takes yet. Share an insight, caveat, or question.
PAF-AH inhibition remains unsupported in CAD; leaves open whether it would accelerate or decelerate atherosclerosis.
Chu‐Huang Chen (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: